Why Are Investors Bullish on These 4 Stocks Today?

Page 2 of 2

Next on our list is Cara Therapeutics Inc (NASDAQ:CARA), whose stock has gained over 7% so far today. The shares of the biotech company rallied on the back of its financial results for the third quarter of fiscal 2015, which included a net loss of $4.8 million, or $0.19 per share, compared to a net loss of $6.5 million, or $0.29 per basic and diluted share for the same period of 2014. The company´s revenue increased by 117.9% year-over-year to $2.44 million. Both revenue and EPS managed to beat the estimates by $0.67 million and $0.08, respectively. In addition, the company has announced that the Phase 2a trial of Oral CR845 in osteoarthritis patients is fully enrolled.

During the third quarter, Cara Therapeutics Inc (NASDAQ:CARA) gained some support from the smart money investors that we track, as the number of the funds invested in the stock increased to 14 from 12; they amassed around 11.5% of the company at the end of September. Jerome Pfund and Michael Sjostrom‘s Sectoral Asset Management is the largest shareholder of Cara Therapeutics with 1.02 million shares worth $14.62 million disclosed in its latest 13F filing.

Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY)’s stock opened higher but has since lost most of the gained ground. The company has also reported its third-quarter results, posting EPS of $0.12, beating analyst estimates by $0.09 per share, while revenue of $192.8 million, went up by 17.9% on the year and was above the $185.40 million figure projected by analysts. Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) also delivered an 8.8% comparable store sales growth in the third quarter. Despite a 6% reduction in its holding, Columbus Circle Investors remained the largest shareholder of Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) among the funds we track. In its latest 13F filing, the fund reported ownership of 603,671 shares worth $22.84 million. Overall, the number of funds with long positions stood at 23 at the end of September, down from 26 three months earlier. These funds held in aggregate 10.6% of the company’s outstanding stock.

Disclosure: none

Page 2 of 2